Your puppy has been immunized with NeoPar and NeoVac DA2 vaccines.  Many veterinarians are not familiar with this protocol.  Below is the information they may need to familiarize themselves with these products.  If they have additional questions, I have listed Dr. Hatler’s contact information at the end of this information.  Ben Hatler began working as NEOTECH’s Director of Operations in the fall of 2004. He serves as NEOTECH’s USDA liaison, is the head of the Animal Research Department, and oversees Research and Development.



Manufacturer: NeoTech
This treatment applies to Dogs.
Canine Parvovirus Vaccine
Modified Live Virus
For use in dogs only.

Product Description:
NeoPar® is a modified live virus vaccine containing a high antigenic mass per dose of a highly immunogenic strain of canine parvovirus.

Gentamicin and Amphotericin B are used as preservatives.

NeoPar® Indications:
NeoPar® is for the vaccination of healthy dogs against disease due to canine parvovirus. NeoPar® is designed to be used primarily where the severe threat of canine parvovirus infections exists in the resident dog population.
This vaccine gives reliable protection against infections by other known strains of canine parvovirus.

NeoPar® overrides moderate to high antibody levels such as those found in puppies having maternal antibodies or in dogs from pre-existing vaccination. It can be used successfully as a booster for a pre-existing vaccination.

Puppies vaccinated with NeoPar® generated high levels of the IgM and IgG classes of antibodies. Secretory immunity was engendered in the gut. Reversion to virulence does not occur. Field studies indicate that this vaccine is safe in puppies at or about 35 days of age or older.


NeoVac® DA2

Manufacturer: NeoTech
This treatment applies to Dogs.
Canine Distemper-adenovirus Type 2 Vaccine
Modified Live Virus

Core Disease Protection
Contains the essential viruses for core protection against the most lethal and prevalent respiratory diseases of dogs.

Maximum Protection
Contains a High Antigen Mass (more vaccine units per dose) which results in

  • Short period from vaccination to protection
  • Higher level of protection (many times greater than the level needed for basic protection)
  • Long duration of immunity

Early Age Protection
Stimulates antibody production in the presence of existing maternal antibodies

First Dose Protection
Starts antibody production with the first dose. Other DA2 vaccines require two to three doses to stimulate an initial antibody response

Simple Vaccine Combination
Eliminates the need to use multi-way “adult vaccines” in the young puppy
More efficient in stimulating antibody production than complex combination vaccines

Found to be safe for use in young puppies No post–vaccination shedding of canine distemper virus; therefore, no chance of vaccine induced disease
Less likely to produce a “vaccine reaction” than complex combination vaccines



Vaccination Schedule per Neotech

35 days (5 weeks) of age
NEOPAR® (Canine Parvovirus Vaccine)

42 days (6 weeks) of age
NEOVAC® DA2 (Canine Distemper-Adenovirus Type 2 Vaccine)

49 days (7 weeks) of age
NEOPAR® (Canine Parvovirus Vaccine)

56 days (8 weeks) of age
NEOVAC® DA2  (Canine Distemper-Adenovirus Type 2 Vaccine)

70 days (10 weeks) of age
NEOPAR® (Canine Parvovirus Vaccine)
NEOVAC® DA2 (Canine Distemper-Adenovirus Type 2 Vaccine)

98 days (14 weeks) of age
NEOPAR® (Canine Parvovirus Vaccine)
NEOVAC® DA2 (Canine Distemper-Adenovirus Type 2 Vaccine)

*Administer Rabies vaccine according to state law

For questions regarding these vaccines, please contact Neotech:

Fax: 731.364.5860
Mailing Address:
10061 Hwy 22
Dresden, TN 38225

Phone & Email



Hopkins County, Texas